| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 03/18/24 | UPLOAD | SEC-generated letter |
|
1 | |
| 03/15/24 | 3 | Initial statement of beneficial ownership of securities |
|
1 | |
| 03/15/24 | 8-K | Current report filing |
|
   |
3 |
| 03/12/24 | S-1 | General form of registration statement for all companies including face-amount certificate companies |
|
29 | |
| 03/06/24 | DEF 14A | Definitive proxy statements |
|
38 | |
| 03/01/24 | 8-K | Current report filing |
|
|
3 |
| 02/16/24 | 8-K | Current report filing |
|
|
115 |
| 02/16/24 | D | Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act. |
|
5 | |
| 02/16/24 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
39 | |
| 02/14/24 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
3 |
Lexaria Bioscience Corp.
Lexaria Bioscience Corp.